90
Participants
Start Date
December 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Liposomal Bupivacaine
10 ml of 0.25% bupivacaine expanded with 133 mg (10 ml volume) of liposomal bupivacaine into both the adductor canal and iPACK blocks (total of 40 ml)
Bupivacaine, Clonidine, Epinephrine, Buprenorphine and Dexamethasone (BPV-CEBD) Combination
20 ml of solution consisting of 0.25% bupivacaine, 1.667mcg/ml of clonidine, 1:400,000 epinephrine, 0.15 mg total of buprenorphine, and 2 mg total of preservative free dexamethasone which will be used in both the adductor canal block and iPACK block (total of 40 ml)
Atrium Health Wake Forest Baptist, Winston-Salem
Wake Forest University Health Sciences
OTHER